Viralgen announces planned CEO succession

Markets PR Newswire By PR Newswire 19 Oct 2026 12:00 1 min read
Viralgen announces planned CEO succession

DONOSTIA / SAN SEBASTIÁN, Spain, Oct. 19, 2026 /PRNewswire/ -- Viralgen, a leading contract development and manufacturing organization (CDMO) specializing in adeno-associated virus (AAV) gene therapy manufacturing, a subsidiary of AskBio, Inc. within the Bayer Group, today announced that...

Covered in this story

What has happened since

Price move measured from the close nearest publication to the latest quote.

Call it yourself

No calls on $ASB yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Associated Bancorp →
Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.